Authors


Melvyn Rubenfire*, MD *These authors contributed equall

Latest:

A Transitional Care Model for Patients With Acute Coronary Syndrome

This study suggests that the Bridging the Discharge Gap Effectively (BRIDGE) program can help decrease the number of hospital readmissions in patients with acute coronary syndrome that cause unnecessary and substantial healthcare systems costs.


Nick D. Williams, MA, PhD

Latest:

Reasons for Emergency Department Use: Do Frequent Users Differ?

Frequent emergency department (ED) users gave similar reasons for using the ED rather than a clinic compared to other patients, including concerns around convenience, access, and quality.


Asif Shaikh, MD

Latest:

Initiation of Triple Therapy Maintenance Treatment Among Patients With COPD

Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.


Talar W. Markossian, PhD, MPH

Latest:

Characteristics and Medication Use of Veterans in Medicare Advantage Plans

Veterans enrolled in Medicare Advantage plans differed from fee-for-service sector enrollees in several demographic, geographic, and clinical characteristics and in patterns of medication use.


Judith J. Stephenson, SM

Latest:

Subacute Lack of Asthma Control as a Predictor of Subsequent Acute Asthma Exacerbation in a Managed Care Population

Subacute lack of asthma control (SALAC) predicts subsequent asthma exacerbation and may improve health plan members’ asthma control and healthcare utilization associated with asthma exacerbation.


Gregory W. Kurtzman, BA

Latest:

Patient and Physician Predictors of Hyperlipidemia Screening and Statin Prescription

Physician and patient predictors of hyperlipidemia screening and statin prescription at a large, multihospital regional health center based on electronic health record data.





Iskra Pusic, MD

Latest:

Economic Evaluation of Plerixafor for Stem Cell Mobilization

Use of granulocyte colony-stimulating factor plus plerixafor for stem cell mobilization is cost-effective in pretreated patients with non-Hodgkin lymphoma.



Renee H. Lawrence, PhD

Latest:

Evaluating a Hepatitis C Quality Gap: Missed Opportunities for HCV-Related Care

Management of hepatitis C screening results can be optimized to ensure that patients receive high-quality care, reducing morbidity and costs related to the virus.


Edmund Pezalla, MD, MPH

Latest:

Pharmacists as Healthcare Providers: Integration Into the Mainstream

On the second day of "Patient-Centered Diabetes Care: Putting Theory Into Practice," Jan Berger, MD, MJ, president of Health Intelligence Partners, moderated the panel discussion "Measuring the Impact of Pharmacists in Diabetes Patient Care."





Zakary Kelly, MBA

Latest:

The Escalation of the Opioid Epidemic Due to COVID-19 and Resulting Lessons About Treatment Alternatives

Factors worsening the opioid epidemic during the coronavirus disease 2019 (COVID-19) pandemic provide valuable insight for strategy change where we have historically suffered great loss, bodily and financially.



Jack Newsom, ScD

Latest:

Increasing Preventive Health Services via Tailored Health Communications

The authors describe and apply a methodology for defining tailored health communications in order to increase the number of completed colorectal cancer screenings.



Anna Feldman, MD

Latest:

CHAPTER 3. Guideline for Detection and Management of Diabetes in Pregnancy

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts





Craig Evan Pollack, MD, MHS

Latest:

Are Primary Care Physicians Ready to Practice in a Consumer-Driven Environment?

National survey reveals primary care physicians have low knowledge of consumer-directed health plans and limited readiness to engage patients on issues of cost and quality.



Paul C. Nagle, BSBA

Latest:

Characteristics of and Trends in the Late-stage Biopharmaceutical Pipeline

Research on characteristics of the biopharmaceutical pipeline and on changes since 2003 includes a description of new features and recommendations for health policy decision makers.


Kevin G. Volpp, MD, PhD

Latest:

Imagining a World Without Low-Value Services: Progress, Barriers, and the Path Forward

Clinician-, patient-, and research-focused initiatives are needed to reduce the delivery of low-value care services that contribute to financial, clinical, and psychological harm for patients.



William P. McGreevey, PhD

Latest:

Type 2 Diabetes Mellitus in China: A Preventable Economic Burden

Treatment of type 2 diabetes mellitus and its complications places a heavy burden on healthcare budgets in China and will continue to do so.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo